Ida Colantonio

853 total citations
39 papers, 596 citations indexed

About

Ida Colantonio is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology. According to data from OpenAlex, Ida Colantonio has authored 39 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 14 papers in Otorhinolaryngology. Recurrent topics in Ida Colantonio's work include Head and Neck Cancer Studies (14 papers), Lung Cancer Treatments and Mutations (14 papers) and Lung Cancer Research Studies (6 papers). Ida Colantonio is often cited by papers focused on Head and Neck Cancer Studies (14 papers), Lung Cancer Treatments and Mutations (14 papers) and Lung Cancer Research Studies (6 papers). Ida Colantonio collaborates with scholars based in Italy, United Kingdom and United States. Ida Colantonio's co-authors include Marco Merlano, Gianmauro Numico, Ornella Garrone, Milena Gasco, Elena Fea, Elvio Russi, Nicola Silvestris, Cristina Granetto, Marcella Occelli and Nerina Denaro and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Ida Colantonio

38 papers receiving 581 citations

Peers

Countries citing papers authored by Ida Colantonio

Since Specialization

Citations

This map shows the geographic impact of Ida Colantonio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ida Colantonio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ida Colantonio more than expected).

Fields of papers citing papers by Ida Colantonio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ida Colantonio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ida Colantonio. The network helps show where Ida Colantonio may publish in the future.

Co-authorship network of co-authors of Ida Colantonio

This figure shows the co-authorship network connecting the top 25 collaborators of Ida Colantonio. A scholar is included among the top collaborators of Ida Colantonio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ida Colantonio. Ida Colantonio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patients with cancer and hospital admissions: disease trajectory and strategic choices 2023 ·BMJ Supportive & Palliative Care ·Gianmauro Numico, (unknown), Elena Fea, (unknown), Ida Colantonio, Marcella Occelli, Anna Maria Vandone, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Roberto Ippoliti	2
2	A phase II, Open-Label, Single-Arm Trial of Carboplatin Plus Etoposide with Bevacizumab and Atezolizumab in Patients with Extended-Stage Small-Cell Lung Cancer (CeLEBrATE study): Background, Design and Rationale 2022 ·Future Oncology ·Elisa Andrini, Giuseppe Lamberti, Francesca Mazzoni, Ferdinando Riccardi, Andrea Bonetti, Alessandro Follador, Fabrizio Artioli, Carlo Genova, Fausto Barbieri, Antonio Frassoldati, Matteo Brighenti, Ida Colantonio, Giulia Pasello, Corrado Ficorella, Saverio Cinieri, Marcello Tiseo, Francesco Gelsomino, Michele Tognetto, Karim Rihawi, Andrea Ardizzoni	6
3	Molecular profiling of advanced non-small cell lung cancer in the era of immunotherapy approach: a multicenter Italian observational prospective study of biomarker screening in daily clinical practice 2021 ·Journal of Clinical Pathology ·Tiziana Vavalà, Umberto Malapelle, Claudia Veggiani, Vienna Ludovini, Mauro Papotti, Alvaro Leone, Paolo Graziano, Roberta Minari, Francesca Bono, Anna Sapino, (unknown), Giancarlo Troncone, Pasquale Pisapia, Salvatore Girlando, L Buffoni, Luisella Righi, Ida Colantonio, Oscar Bertetto, Silvia Novello	2
4	Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL) 2020 ·British Journal of Cancer ·Francesco Gelsomino, Marcello Tiseo, Fausto Barbieri, Ferdinando Riccardi, Luigi Cavanna, Antonio Frassoldati, Angelo Delmonte, Lucia Longo, Claudio Dazzi, Saverio Cinieri, Ida Colantonio, Francesca Sperandi, Giuseppe Lamberti, Stefano Brocchi, Lorenzo Tofani, Luca Boni, Andrea Ardizzoni	19
5	Treating patients with cancer amidst the COVID-19 pandemic: experience of a regional hospital in the Piedmont region in northern Italy 2020 ·Tumori Journal ·Ornella Garrone, Nerina Denaro, Fiorella Ruatta, (unknown), Cristina Granetto, Anna Maria Vandone, Marcella Occelli, (unknown), Vincenzo Ricci, Elena Fea, (unknown), Ida Colantonio, Nicola Crosetto, Marco Merlano	1
6	Metronomic oral cyclophosphamide (CTX) in patients (pts) with heavily pretreated metastatic castration-resistant prostate cancer (mCRPC) 2016 ·Annals of Oncology ·Elena Fea, (unknown), (unknown), (unknown), Ida Colantonio, Nerina Denaro, Giuseppe Costanzo, Ornella Garrone, Cristina Granetto, Marcella Occelli, Vincenzo Ricci, Anna Maria Vandone, (unknown)	2
7	Prolonged Drainage and Intrapericardial Bleomycin Administration for Cardiac Tamponade Secondary to Cancer-Related Pericardial Effusion 2016 ·Medicine ·Gianmauro Numico, (unknown), Marcella Occelli, Marco Sicuro, (unknown), Elena Fea, Ida Colantonio, Marco Merlano, (unknown), Nicola Silvestris	20
8	Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study 2015 ·Annals of Oncology ·Fausto Roila, Benedetta Ruggeri, Enzo Ballatori, Sonia Fatigoni, Claudia Caserta, Lisa Licitra, Aurora Mirabile, (unknown), B. Massidda, Luigi Cavanna, Maria Angela Palladino, Angelo Tocci, S. Fava, Ida Colantonio, Lucia Angelelli, L. Ciuffreda, Gianpiero Fasola, (unknown)	24
9	Aprepitant versus metoclopramide, both combined with dexamethasone, for preventing cisplatin-induced delayed emesis: A randomized, double-blind study. 2014 ·Journal of Clinical Oncology ·Fausto Roila, Enzo Ballatori, Benedetta Ruggeri, Sonia Fatigoni, Aurora Mirabile, (unknown), Luigi Cavanna, Sergio Fava, Ida Colantonio, Lucia Angelelli, Libero Ciuffreda, Stefania Eufemia Lutrino, (unknown)	3
10	The Role of Antiangiogenic Agents in the Treatment of Head and Neck Cancer 2012 ·Oncology ·Nerina Denaro, Elvio Russi, Ida Colantonio, Vincenzo Adamo, Marco Merlano	13
11	Impact of age on acute toxicity induced by bio- or chemo-radiotherapy in patients with head and neck cancer 2012 ·Oral Oncology ·Marco Merlano, Martino Monteverde, Ida Colantonio, Nerina Denaro, Cristiana Lo Nigro, Guido Natoli, (unknown), Gianmauro Numico, Elvio Russi	44
12	Survival prediction and frequency of anticancer treatment in cancer patients hospitalized due to acute conditions. Role of clinical parameters and PaP score 2011 ·Supportive Care in Cancer ·Gianmauro Numico, Marcella Occelli, Elvio Russi, Nicola Silvestris, (unknown), Elena Fea, Cristina Granetto, (unknown), Ida Colantonio, Milena Gasco, Ornella Garrone, (unknown), Marco Merlano	16
13	The effects on pain and activity of daily living caused by crusted exudation in patients with head and neck cancer treated with cetuximab and radiotherapy 2011 ·Supportive Care in Cancer ·Elvio Russi, Marco Merlano, Gianmauro Numico, Renzo Corvò, Marco Benasso, (unknown), (unknown), Nerina Denaro, Stefano Pergolizzi, Ida Colantonio, (unknown), (unknown), Umberto Ricardi	8
14	Postoperative Therapy in Head and Neck Cancer: State of the Art, Risk Subset, Prognosis and Unsolved Questions 2011 ·Oncology ·Nerina Denaro, Elvio Russi, Vincenzo Adamo, Ida Colantonio, Marco Merlano	15
15	Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study 2010 ·Annals of Oncology ·Marco Merlano, Elvio Russi, Marco Benasso, Renzo Corvò, Ida Colantonio, (unknown), (unknown), Almalina Bacigalupo, Gianmauro Numico, Nicola Crosetto, Milena Gasco, Cristiana Lo Nigro, (unknown), (unknown), Ornella Garrone	60
16	Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: A pharmacology-guided schedule 2006 ·International Journal of Radiation OncologyBiologyPhysics ·Gianmauro Numico, Elvio Russi, (unknown), (unknown), Ida Colantonio, (unknown), (unknown), (unknown), Elena Fea, Cristina Granetto, (unknown), Milena Gasco, Ornella Garrone, Marcella Occelli, Marco Merlano	15
17	AlteRCC phase I-II trial: Alternating radiotherapy and chemotherapy plus cetuximab in advanced head and neck cancer (HNC) 2006 ·Journal of Clinical Oncology ·(unknown), Gianmauro Numico, Ida Colantonio, Ornella Garrone, Milena Gasco, Elvio Russi, (unknown), Cristina Granetto, Giuseppe Costanzo	1
18	Weekly docetaxel and zoledronic acid every 4 weeks in hormone-refractory prostate cancer patients 2005 ·Cancer Chemotherapy and Pharmacology ·Gianfilippo Bertelli, (unknown), Giuseppe Arena, (unknown), Ornella Garrone, Ida Colantonio, Marcella Occelli, Elena Fea, (unknown), Marco Merlano	17
19	Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine 2005 ·Cancer ·Gianmauro Numico, Ornella Garrone, (unknown), Nicola Silvestris, Ida Colantonio, (unknown), Cristina Granetto, Marcella Occelli, Elena Fea, (unknown), Milena Gasco, Marco Merlano	166
20	Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study 2004 ·Cancer Chemotherapy and Pharmacology ·M Schena, C. Barone, Nadia Birocco, (unknown), Gianmauro Numico, Ida Colantonio, Oscar Bertetto	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact